
Pan-Immune-Inflammation Value as a Prognostic Biomarker for Hepatocellular Carcinoma Patients Undergoing Hepatectomy
Introduction Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer globally, with the third highest cancer-related mortality.1 Due to difficulties in early diagnosis and lack of effective treatment, the five-year survival rate of HCC is less …